United States · FDA National Drug Code directory
NAPROXEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-136_2be91642-ea9b-b147-e063-6394a90a2d96
- Product NDC
- 72189-136
- Form
- TABLET
- Composition / generic term
- NAPROXEN
- Labeler
- DIRECT RX
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201015
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET in 1 BOTTLE (72189-136-14) · 72189-136-14
- 20 TABLET in 1 BOTTLE (72189-136-20) · 72189-136-20
- 30 TABLET in 1 BOTTLE (72189-136-30) · 72189-136-30
- 60 TABLET in 1 BOTTLE (72189-136-60) · 72189-136-60
- 100 TABLET in 1 BOTTLE (72189-136-71) · 72189-136-71
- 90 TABLET in 1 BOTTLE (72189-136-90) · 72189-136-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →